News Headlines Article

Diet Drug Wins Panel’s Approval
New York Times

Government advisers recommended approval on Thursday of a weight-loss drug developed by Arena Pharmaceuticals, making it likely that a new obesity treatment will reach the market this year. An advisory committee to the Food and Drug Administration voted 18 to 4, with one abstention, that the benefits of the drug, lorcaserin, outweighed the risks.